Mergers & Acquisitions - Generics

Filter

Current filters:

Generics

Popular Filters

1 to 25 of 191 results

Indian pharmaceutical sector to see strong growth, says Moody’s

Indian pharmaceutical sector to see strong growth, says Moody’s

25-08-2014

Moody's Investors Service says that India's pharmaceutical market will continue to grow in the double…

FinancialGenericsIndiaMarkets & MarketingMergers & Acquisitions

Sun Pharma’s takeover of Ranbaxy comes to attention of Competition Commission

Sun Pharma’s takeover of Ranbaxy comes to attention of Competition Commission

11-08-2014

The deal between Indian generics company Sun Pharmaceutical Industries which acquired fellow Indian drug…

CCIGenericsIndiaMergers & AcquisitionsPharmaceuticalRanbaxy LaboratoriesSun Pharmaceutical Industries

Hikma to take over Boehringer’s Ben Venue manufacturing site

24-07-2014

Jordan-based drugmaker Hikma Pharmaceuticals says it has agreed with Ben Venue Laboratories, part of…

Ben Venue LabsBoehringer IngelheimGenericsHikma PharmaceuticalsMergers & AcquisitionsProductionUSA

Pfizer to acquire generics firm InnoPharma for up to $360 million

Pfizer to acquire generics firm InnoPharma for up to $360 million

17-07-2014

Having failed (so far) in its mega billion dollar ($116 billion) attempt to buy Anglo-Swedish drug major…

GenericsInnoPharmaMergers & AcquisitionsOncologyOphthalmicsPfizer

Sun Pharma acquires Pharmalucence

Sun Pharma acquires Pharmalucence

16-07-2014

Sun Pharmaceutical Industries, India's third-largest generic drugmaker by sales, revealed that it has…

BSE SensexEconomy of IndiaGenericsIndiaMergers & AcquisitionsPharmalucenceProductionRanbaxy LaboratoriesSun Pharmaceuticals

Abbott Labs sells branded generics business to Mylan in $5.3 billion deal

Abbott Labs sells branded generics business to Mylan in $5.3 billion deal

14-07-2014

Following a weekend of rumors and speculation, USA-based generics major Mylan and health care firm Abbott…

Abbott LaboratoriesAustraliaCanadaEuropeFinancialGenericsJapanMergers & AcquisitionsMylanNew Zealand

Hospira completes buy of Orchid's API production and R&D facility

Hospira completes buy of Orchid's API production and R&D facility

06-07-2014

US provider of injectable drugs and infusion technologies Hospira says it has completed the acquisition…

GenericsHospiraIndiaMergers & AcquisitionsOrchid Chemicals & PharmaceuticalsProduction

Cipla links with Hetero for biosimilar Aranesp; M&A in Yemen

30-06-2014

Cipla has collaborated with fellow Indian drugmaker Hetero to launch a biosimilar of the drug darbepoetin…

ActoriseAmgenAranespBiosimilarsCiplaGenericsHeteroIndiaMarkets & MarketingMergers & AcquisitionsOncologyRest of the World

Dubai Investments sells 66% stake in Globalpharma to Sanofi

29-06-2014

Dubai Investments PJSC, the leading investment company listed on the Dubai financial market [DFM], has…

GenericsGlobalpharmaMergers & AcquisitionsRest of the WorldSanofi

Endo to acquire generics firm DAVA Pharma for up to $600 million

Endo to acquire generics firm DAVA Pharma for up to $600 million

25-06-2014

Ireland-headquartered Endo International says it has reached a definitive agreement to acquire DAVA Pharmaceuticals,…

DAVA PharmaceuticalsEndo PharmaceuticalsGenericsMergers & Acquisitions

FTC approves final order on Akorn’s acquisition of Hi-Tech

FTC approves final order on Akorn’s acquisition of Hi-Tech

22-06-2014

Following a public comment period, the US Federal Trade Commission on Friday approved a final order settling…

AkornGenericsHi-Tech PharmacalMergers & AcquisitionsUSAValeant Pharmaceuticals International

Meiji Seika Pharma to acquire India’s Medreich for $290 million

Meiji Seika Pharma to acquire India’s Medreich for $290 million

12-06-2014

Japan’s Meiji Seika Pharma revealed today that it intends to acquire all of the outstanding shares…

Asia-PacificGenericsMedreichMeiji Seika PharmaMergers & Acquisitions

AMRI to buy Oso Biopharmaceuticals Manufacturing for $110 million

AMRI to buy Oso Biopharmaceuticals Manufacturing for $110 million

02-06-2014

USA-based Albany Molecular Research has signed a definitive agreement to acquire all of the outstanding…

Albany Molecular ResearchGenericsMergers & AcquisitionsOso BiopharmaceuticalsProduction

Hikma to buy Boehringer’s Bedford Labs unit for $300 million

Hikma to buy Boehringer’s Bedford Labs unit for $300 million

28-05-2014

Jordon-based drugmaker Hikma Pharmaceuticals has signed an asset purchase agreement with Ben Venue Laboratories,…

Bedford LaboratoriesBoehringer IngelheimGenericsHikma PharmaceuticalsMergers & AcquisitionsUSA

Recordati finalizes second tranche of Opalia Pharma acquisition

27-05-2014

Following previous announcements about its M&A activity, Italian drugmaker Recordati has now announced…

GenericsMergers & AcquisitionsOpalia PharmaRecordatiRest of the World

Indian court ruling lifts temporary stay on Sun Pharma takeover of Ranbaxy

26-05-2014

Indian generics drugmaker Sun Pharmaceuticals’ proposed $3.2 billion acquisition of loss-making rival…

Daiichi SankyoGenericsLegalMergers & AcquisitionsRanbaxy LaboratoriesSun Pharmaceuticals

Abbott spends $2.9 billion on CFR Pharma to expand Latin American presence

16-05-2014

US drugmaker Abbott has signed an agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals,…

Abbott LaboratoriesCFR PharmaceuticalsGenericsMergers & AcquisitionsSouth America

Fresenius Kabi expands IV drug business in Latin America with buy of Novafarma

Fresenius Kabi expands IV drug business in Latin America with buy of Novafarma

13-05-2014

Germany-based Fresenius Kabi has entered into an agreement to acquire the privately held Brazilian pharmaceutical…

BrazilFresenius KabiGenericsMergers & AcquisitionsNovafarma Industria Farmaceutica

Akorn to acquire VersaPharm for $440 million

Akorn to acquire VersaPharm for $440 million

10-05-2014

Following swiftly on its completion of the acquisition of Hi-Tech Pharmacal (Nasdaq: HITK) for $640 million…

AkornDermatologicalsGenericsMergers & AcquisitionsVersaPharm

Sun Pharma vows “appropriate action” as Ranbaxy merger halted

05-05-2014

In the wake of a suspension of its proposed $4 billion acquisition of domestic rival Ranbaxy Laboratories…

GenericsIndiaMergers & AcquisitionsProductionRanbaxy LaboratoriesSun Pharmaceutical IndustriesUSA

1 to 25 of 191 results

Back to top